Abstract
IntroductionPolypharmacy and multimorbidity pose escalating challenges. Despite numerous attempts, interventions have yet to show consistent improvements in health outcomes. A key factor may be varied approaches to targeting patients for...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have